Adaptimmune to Report Q1 Financial Results on Thursday, May 14, 2020

NEXT STORY
Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models
PREV STORY
SIGA Technologies to Host Business Update Call on May 6, 2020 after Release of First Quarter Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

In-Vitro Diagnostics (IVD) Market Slated to Bring in USD 102,554.24 million by End of 2023 | POC Testing to Expedite In-vitro Diagnostics Industry Demand, Says MRFR

author_avatar
NASDAQ Market News

$107B+ In-Vitro Diagnostics Market Outlook, 2020-2027 – Increasing Adoption and Popularity of Automation in Clinical Laboratories

author_avatar
NASDAQ Market News

Teleflex to Present at the Raymond James 2021 Human Health Innovation Conference

author_avatar
NASDAQ Market News